2TZ Stock Overview
Produces and sells traditional Chinese medicine, western medicine, and other products primarily in the People’s Republic of China. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 5/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 2/6 |
My Notes
Capture your thoughts, links and company narrative
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥2.16 |
| 52 Week High | CN¥2.39 |
| 52 Week Low | CN¥1.52 |
| Beta | 0.80 |
| 1 Month Change | 0% |
| 3 Month Change | 0.98% |
| 1 Year Change | 23.51% |
| 3 Year Change | 123.77% |
| 5 Year Change | 199.72% |
| Change since IPO | 191.23% |
Recent News & Updates
Recent updates
Shareholder Returns
| 2TZ | DE Pharmaceuticals | DE Market | |
|---|---|---|---|
| 7D | 0% | 1.2% | 1.2% |
| 1Y | 23.5% | -14.1% | 10.1% |
Return vs Industry: 2TZ exceeded the German Pharmaceuticals industry which returned -14.1% over the past year.
Return vs Market: 2TZ exceeded the German Market which returned 10.1% over the past year.
Price Volatility
| 2TZ volatility | |
|---|---|
| 2TZ Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 5.5% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 11.5% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: Data is not available.
Volatility Over Time: Insufficient data to determine 2TZ's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1981 | 4,619 | n/a | www.jydrt.com.cn |
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited, together with its subsidiaries, produces and sells traditional Chinese medicine, western medicine, and other products primarily in the People’s Republic of China. The company manufactures and sells of biochemical pharmaceutical products. It also engages in research and development of chinese patent medicines, chemical raw materials and preparations, and nutritional supplements.
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Fundamentals Summary
| 2TZ fundamental statistics | |
|---|---|
| Market cap | €2.65b |
| Earnings (TTM) | €123.58m |
| Revenue (TTM) | €1.07b |
24.1x
P/E Ratio2.8x
P/S RatioIs 2TZ overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 2TZ income statement (TTM) | |
|---|---|
| Revenue | CN¥8.04b |
| Cost of Revenue | CN¥4.30b |
| Gross Profit | CN¥3.74b |
| Other Expenses | CN¥2.81b |
| Earnings | CN¥932.37m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Mar 31, 2025
| Earnings per share (EPS) | 1.21 |
| Gross Margin | 46.50% |
| Net Profit Margin | 11.60% |
| Debt/Equity Ratio | 19.8% |
How did 2TZ perform over the long term?
See historical performance and comparisonDividends
4.4%
Current Dividend Yield106%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/10 15:27 |
| End of Day Share Price | 2024/11/15 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited is covered by 9 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Yalei Yan | Bohai Securities Co., Ltd. |
| Chengzhi Chen | CGS International |
| Shanshan Li | China Merchants Securities Co. Ltd. |